O'Melveny & Myers LLP 1999 Avenue Of The Stars, Los Angeles, CA 90067 2134307670 (Office), 2134306407 (Fax)
Licenses:
California - Active 2005
Education:
University of Pennsylvania Law School Degree - JD - Juris Doctor - Law Yale University Degree - BA - Bachelor of Arts - English Language Yale University Degree - BA - Bachelor of Arts - English Literature
Business Trial and Litigation White Collar Defense and Corporate Investigations
ISLN:
918618823
Admitted:
2005
University:
University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; Wharton School of Business; Yale University, B.A.; Yale University, B.A.
Law School:
University of Pennsylvania Law School, JD - Juris Doctor
Louise Chen - Lawyer
Googleplus
Louise Chen
Education:
National Taiwan University - Chinese Literature, Simon Fraser University - Advanced Interpreter Program
Louise Chen (1979-1981), Lisa Carter (1976-1980), Stacy Romanoff (1972-1977), Richard Born (1972-1975), Karla Ortega (1964-1968), Steven Cook (1978-1982)
depends on the outcome of an ongoing Phase 3 trial of the drug non-hospitalized Covid-19 patients with at least one risk factor for poor disease outcomes. In a note last month, Cantor Fitzgerald analyst Louise Chen wrote that the studys primary completion date would likely be in September or October.
Date: Jun 09, 2021
Category: More news
Source: Google
Lilly Reports Strong Sales, Boosted by Covid Antibodies
sales were as good as Wall Street expected, but profits came in about 9% better than the forecasts of analysts polled by FactSet. Lillys likelihood of expanding its profit margins is one of the highest in the industry, said Cantor Fitzgerald analyst Louise Chen, in a note on the Friday results. The
ine, we believe JNJs vaccine could move into the lead given its single-dose regimen, wrote Cantor Fitzgerald analyst Louise Chen in a note out Wednesday. There is a growing consensus that SAR-CoV-2 will become endemic so we think a leading vaccine could drive upside to valuation.
Date: Jan 14, 2021
Category: Headlines
Source: Google
Teva Pharmaceutical will cut 7000 jobs and close plants to reduce costs
We like Teva, but we think the company has some meaningful headwinds which need to be addressed before the stock can trade meaningfully higher, analyst Louise Chen of Cantor Fitzgerald said in a client update. Among the questions: whether Teva will break the company into separate branded drugs a
Date: Aug 03, 2017
Category: Business
Source: Google
Valeant Pharmaceuticals Intl Inc: Can New CFO Help Turn the Company Around
Given the backdrop, Guggenheim Securities analyst Louise Chen said regarding Mr. Herendeens job at Valeant: Its going to be a cleanup role. The first thing they have to do is string together a couple of good quarters.
Date: Aug 23, 2016
Category: Business
Source: Google
Jazz Pharma's much-delayed rare liver disease drug finally wins FDA approval
The drug took in sales of $70.7 million in Europe last year, with analyst Louise Chen from Guggenheim expecting the drug to add $6.64 to Jazz's profit per share in 2016. Chen added in a recent note to clients that Defibrotide's sales could also help lower Ireland-based Jazz's tax rate. The price tag
Date: Mar 31, 2016
Category: Health
Source: Google
Hospira Rises After CEO Says Production Rebounds: Chicago Mover
Hospira had an okay quarter that defied expectations, said Louise Chen, a Collins Stewart LLC analyst in New York, in an e-mail. The company credited strong sales of docetaxel, its chemotherapy drug, for the results and will have to show investors the gains are sustainable, Chen said.
Date: Feb 14, 2012
Category: Business
Source: Google
Hospira Rises After Drug Production Rebounds: Chicago Mover
The fact that there is no consent decree in the near- term cheered investors, said Louise Chen, a Stewart Collins LLC analyst in New York, in a telephone interview. Now, you know the bottom and thats helpful.